Monoaminergic impairment in Down syndrome with Alzheimer's disease compared to early-onset Alzheimer's disease

INTRODUCTION: People with Down syndrome (DS) are at high risk for Alzheimer's disease (AD). Defects in monoamine neurotransmitter systems are implicated in DS and AD but have not been comprehensively studied in DS. METHODS: Noradrenaline, adrenaline, and their metabolite 3-methoxy-4-hydroxyphen...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Alzheimers Dement (Amst)
Hlavní autoři: Dekker, Alain D., Vermeiren, Yannick, Carmona-Iragui, Maria, Benejam, Bessy, Videla, Laura, Gelpi, Ellen, Aerts, Tony, Van Dam, Debby, Fernández, Susana, Lleó, Alberto, Videla, Sebastian, Sieben, Anne, Martin, Jean-Jacques, Blesa, Rafael, Fortea, Juan, De Deyn, Peter P.
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2017
Témata:
CSF Biomarkers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5956808/
https://ncbi.nlm.nih.gov/pubmed/29780859
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2017.11.001
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky